Enhanced anti-metastatic activity of etoposide using layered double hydroxide nano particles

Journal of Biomedical Nanotechnology

Volumn 11, Issue 12, 2015, Pages 2158-2168

  Zhu, Yanjing ^a   Wu, Youjun ^a   Zhang, Haixia ^a   Wang, Zhaoqi ^a   Wang, Shilong ^a   Qian, Yechang ^b   Zhu, Rongrong ^a  

^a TONGJI UNIVERSITY   (China)

^b Shanghai Baoshan Central Hospital   (China)

Author keywords

Cell invasion; Cell migration; Drug delivery; Etoposide; Layered double hydroxides; MTOR AKT

Indexed keywords

ANTIBIOTICS; CELLS; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; CYTOLOGY; DISEASES; DRUG DELIVERY; FLUORESCENCE; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CELL INVASION; CELL MIGRATION; ETOPOSIDE; LAYERED DOUBLE HYDROXIDES; MTOR/AKT;

TARGETED DRUG DELIVERY;

BETA CATENIN; ETOPOSIDE; HYDROXIDE; LAYERED DOUBLE HYDROXIDE NANOPARTICLE; MAMMALIAN TARGET OF RAPAMYCIN; NANOPARTICLE; NYSTATIN; PROTEIN KINASE B; STAT3 PROTEIN; SUCROSE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; HYDROXIDE ION;

A549 CELL LINE; ARTICLE; BIOSAFETY; CANCER INHIBITION; CAVEOLA; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; DOWN REGULATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG UPTAKE; ENDOCYTOSIS; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TEMPERATURE; INCUBATION TIME; METASTASIS; METASTASIS INHIBITION; NANOENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SLOW DRUG RELEASE; SURFACE PROPERTY; TIMED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR INVASION; UPREGULATION; X RAY DIFFRACTION; ZETA POTENTIAL; CELL MOTION; CHEMISTRY; DRUG EFFECTS; DRUG RELEASE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL MOVEMENT; DRUG CARRIERS; DRUG LIBERATION; ETOPOSIDE; HUMANS; HYDROXIDES; NANOPARTICLES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PARTICLE SIZE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84953343996     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2015.2164     Document Type: Article

References (44)

1. World Cancer Report 2014, World Health Organization (2014), pp. Chap. 1. 1.
2. C. A. Klein, Cancer, The metastasis cascade. Science 321, 1785 (2008).
3. R. Siegel, D. Naishadham, and A. Jemal, Cancer statistics, 2013. CA. Cancer J. Clin. 63, 11 (2013).
4. G. P. Gupta and J. Massagué, Cancer metastasis: Building a framework. Cell 127, 679 (2006).
5. D. E. Gomez, G. Skilton, D. F. Alonso, and M. G. Kazanietz, The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (Review). Oncol. Rep. 6, 1363 (1999).
6. D. X. Nguyen and J. Massagué, Genetic determinants of cancer metastasis. Nat. Rev. Genet. 8, 341 (2007).
7. P. Friedl and K. Wolf, Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat. Rev. Cancer. 3, 362 (2003).
8. S. Maya, B. Sarmento, V. K. Lakshmanan, D. Menon, and R. Jayakumar, Actively targeted cetuximab conjugated gammapoly( glutamic acid)-docetaxelnanomedicines for epidermal growth factor receptor over expressing colon cancer cells. J. Biomed. Nanotechnol. 10, 1416 (2014).
9. C. R. Chong, L. J. Wirth, M. Nishino, A. B. Chen, L. M. Sholl, M. H. Kulke, C. J. McNamee, P. A. Jänne, and B. E. Johnson, Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors. Lung Cancer 86, 241 (2014).
10. M. Gordaliza, P. A. García, J. M. del Corral, M. A. Castro, and M. A. Gómez-Zurita, Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives. Toxicon. 44, 441 (2004).
11. W. Ha, H. Wu, X. L. Wang, S. L. Peng, L. S. Ding, S. Zhang, and B. J. Li, Self-aggregates of cholesterol-modified carboxymethyl konjac glucomannan conjugate: Preparation, characterization, and preliminary assessment as a carrier of etoposide. Carbohydr. Polym. 86, 513 (2011).
12. W. Wang, R. Zhu, Q. Xie, A. Li, Y. Xiao, K. Li, H. Liu, D. Cui, Y. Chen, and S. Wang, Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int. J. Nanomedicine 7, 3667 (2012).
13. X. Yang, Y. Liu, C. Liu, and N. Zhang, Biodegradablesolid lipid nanoparticle flocculates for pulmonary delivery of insulin. J. Biomed. Nanotechnol. 8, 834 (2012).
14. R. H. Müller, K. Mäder and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery-A review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161 (2000).
15. L. Wang, Y. Liu, W. Li, X. Jiang, Y. Ji, X. Wu, L. Xu, Y. Qiu, K. Zhao, T. Wei, Y. Li, Y. Zhao, and C. Chen, Selective targeting of gold nanorods at the mitochondria of cancer cells: Implications for cancer therapy. Nano Lett. 11, 772 (2011).
16. N. Rozanova and J. Z. Zhang, Metal and magnetic nanostructures for cancer detection, imaging, and therapy. J. Biomed. Nanotechnol. 4, 377 (2008).
17. R. Ramachandran, G. L. Malarvizhi, P. Chandran, N. Gupta, D. Menon, D. Panikar, S. Nair, and M. Koyakutty, A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing. J. Biomed. Nanotechnol. 10, 1401 (2014).
18. B. F. Patricio, S. AlbernazMde, M. A. Sarcinelli, S. M. de Carvalho, R. Santos-Oliveira, and G. Weissmüller, Development of novel nanoparticle for bone cancer. J. Biomed. Nanotechnol. 10, 1242 (2014).
19. Y. Pan, H. Ding, L. Qin, X. Zhao, J. Cai, and B. Du, Gold nanoparticles induce nanostructural reorganization of VEGFR2 to repress angiogenesis. J. Biomed. Nanotechnol. 9, 1746 (2013).
20. Q. Wang and D. O'Hare, Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets. Chem. Rev. 112, 4124 (2012).
21. C. Aguzzi, P. Cerezo, C. Viseras, and C. Caramella, Use of clays as drug delivery systems: Possibilities and limitations. Appl. Clay Sci. 36, 22 (2007).
22. J. H. Choy, S. Y. Kwak, Y. J. Jeong, and J. S. Park, Inorganic layered double hydroxides as nonviral vectors. Angew. Chem. Int. Ed Engl. 39, 4041 (2000).
23. J. H. Choy, S. Y. Kwak, J. S. Park, Y. J. Jeong, and J. Portier, Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J. Am. Chem. Soc. 121, 1399 (1999).
24. A. I. Khan, L. Lei, A. J. Norquist, and D. O'Hare, Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide. Chem. Commun. (Camb) 22, 2342 (2001).
25. M. Z. bin Hussein, Z. Zainal, A. H. Yahaya, and D. W. Foo, Controlled release of a plant growth regulator, alpha-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite. J. Control Release 82, 417 (2002).
26. V. Ambrogi, G. Fardella, G. Grandolini, and L. Perioli, Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents-I, Intercalation and in vitro release of ibuprofen. Int. J. Pharm. 220, 23 (2001).
27. C. Zhang, T. Lan, J. Hou, J. Li, R. Fang, Z. Yang, M. Zhang, J. Liu, and B. Liu, NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling. Oncotarget. 5, 4392 (2014).
28. T. Nakamura, K. Matsumoto, A. Kiritoshi, Y. Tano, and T. Nakamura, Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res. 57, 3305 (1997).
29. X. Huang, J. Zhuang, X. Teng, L. Li, D. Chen, X. Yan, and F. Tang, The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species. Biomaterials 31, 6142 (2010).
30. Z. Yang, B. Yu, J. Zhu, X. Huang, J. Xie, S. Xu, X. Yang, X. Wang, B. C. Yung, L. J. Lee, R. J. Lee, and L. Teng, A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia. Nanoscale 6, 9742 (2014).
31. X. Liu, Z. Wang, R. Feng, Y. Hu, and G. Huang, A novel approach for systematic delivery of a hydrophobic anti-leukemia agent tamibarotene mediated by nanostructured lipid carrier. J. Biomed. Nanotechnol. 9, 1586 (2013).
32. A. Sengupta, S. C. Kelly, N. Dwivedi, N. Thadhani, and M. R. Prausnitz, Efficient intracellular delivery of molecules with high cell viability using nanosecond-pulsed laser-activated carbon nanoparticles. ACS Nano 8, 2889 (2014).
33. M. S. Rocha, C. M. Lucci, J. P. Longo, P. D. Galera, A. R. Simioni, Z. G. Lacava, A. C. Tedesco, and R. B. Azevedo, Aluminumchloride-phthalocyanine encapsulated in liposomes: Activity against naturally occurring dog breast cancer cells. J. Biomed. Nanotechnol. 8, 251 (2012).
34. Z. J. Deng, S. W. Morton, E. Ben-Akiva, E. C. Dreaden, K. E. Shopsowitz, and P. T. Hammond, Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano 7, 9571 (2013).
35. G. J. Doherty and H. T. McMahon, Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857 (2009).
36. R. G. Parton and K. Simons, The multiple faces of caveolae. Nat. Rev. Mol Cell. Biol. 8, 185 (2007).
37. M. S. Bretscher, Distribution of receptors for transferrin and low density lipoprotein on the surface of giant HeLa cells. Proc. Natl. Acad. Sci. USA 80, 454 (1983).
38. M. S. Bretscher, Getting membrane flow and the cytoskeleton to cooperate in moving cells. Cell 87, 601 (1996).
39. A. V. Bakin, A. K. Tomlinson, N. A. Bhowmick, H. L. Moses, and C. L. Arteaga, Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803 (2000).
40. M. Vaid, R. Prasad, Q. Sun, and S. K. Katiyar, Silymarin targets b-catenin signaling in blocking migration/invasion of human melanoma cells. PLoS One 6, e23000 (2011).
41. G. Gutiérrez-Venegas and P. Cardoso-Jiménez, Lipoteichoic acid promotes nuclear accumulation of-catenin via AKT in human gingival fibroblasts. Int. Immunopharmacol. 11, 1278 (2011).
42. M. M. Monick, A. B. Carter, P. K. Robeff, and D. M. Flaherty, M. W. Peterson, and G. W. Hunninghake, Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J. Immunol. 166, 4713 (2001).
43. L. Raptis, R. Arulanandam, M. Geletu, and J. Turkson, The R(h)oads to Stat3: Stat3 activation by the Rho GTPases. Exp. Cell Res. 317, 1787 (2011).
44. S. Timme, S. Ihde, C. D. Fichter, V. Waehle, L. Bogatyreva, K. Atanasov, I. Kohler, A. Schopflin, H. Geddert, G. Faller, D. Klimstra, L. Tang, T. Reinheckel, D. Hauschke, H. Busch, M. Boerries, M. Werner, and S. Lassmann, STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas. Oncogene 33, 3256 (2014).